Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03325985 · ClinicalTrials.gov registry record · NA
Emergency Medicine Palliative Care Access
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,606
- Enrollment target
NCT03325985 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,606 participants.
The verdict
NCT03325985, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,606 participants
- Enrollment target
Study Summary
This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Disease (ESRD), defined as Glomerular Filtration Rate (GFR) \< 15 ml/min/m2 or dialysis ; or Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage III or higher, or oxygen-dependent chronic obstructive pulmonary disease (COPD) who present to the Emergency Department (ED), along with 675 of their informal caregivers. Investigators will compare the effectiveness of two distinct palliative care models: a) nurse-led telephonic case management; and b) facilitated, outpatient specialty palliative care.
Interventions
- BEHAVIORAL Nurse-led telephonic case management
- BEHAVIORAL Facilitated,outpatient specialty palliative care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,606 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03325985
The ClinicalTrials.gov registry entry for NCT03325985 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,606 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nurse-led telephonic case management is the first listed.
NCT03325985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03325985 about?
NCT03325985 is a clinical study titled "Emergency Medicine Palliative Care Access". This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Dis...
What is the current status of trial NCT03325985?
This trial is currently completed. It is a NA study. The enrollment target is 1,606 participants. The study started on 2018-03-28. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT03325985?
The interventions under investigation include: Nurse-led telephonic case management (BEHAVIORAL), Facilitated,outpatient specialty palliative care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03325985?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.